Novo Nordisk is a global healthcare company that specializes in diabetes care and other chronic diseases. The company was founded in Denmark in 1923 and has since expanded to become a leading provider of insulin and other diabetes treatments. Novo Nordisk operates in more than 80 countries and employs over 43,000 people worldwide. The company is committed to improving the lives of people with diabetes and other chronic conditions through innovative research, development, and manufacturing of pharmaceutical products. Novo Nordisk US is headquartered in Plainsboro, New Jersey and has facilities in several other states including North Carolina and New Hampshire.